NCT01189929 2020-09-09A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerMereo BioPharmaPhase 1 Completed57 enrolled